Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.04
Delayed Data
As of Aug 23
 +0.04 / +4.00%
Today’s Change
0.73
Today|||52-Week Range
8.49
-17.46%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.00
Today’s open1.05
Day’s range1.02 - 1.06
Volume4,393,040
Average volume (3 months)6,630,716
Market cap$306.0M
Dividend yield--
Data as of 08/23/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc0.000.00%
AGENAgenus Inc+0.01+0.28%
EDGEEdge Therapeutics In...-0.05-0.48%
GERNGeron Corp-0.01-0.50%
Data as of 08/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts